Omura N, Kashiwagi H, Aoki T
Second Department of Surgery, Jikei University School of Medicine.
Nihon Shokakibyo Gakkai Zasshi. 1992 Dec;89(12):2754-61.
We investigated the effect of 4-weeks famotidine administration (15 mg/kg/day) on gastrin cell (G-cell), somatostatin cell (D-cell) and prostaglandin E2 (PGE2) of gastric mucosa in pyloric stenosis rats. As a result, the increase of G-cell number and serum gastrin level in pyloric stenosis rats were potentiated by famotidine administration. However, the increase of D-cell number in pyloric stenosis was remarkably abolished by famotidine administration, and G/D cell ratio was increased accordingly. Moreover, famotidine administration decreased PGE2 concentration in fundic mucosa of the stomach without altering PGE2 concentration in pyloric mucosa. Our results suggested that famotidine administration in pyloric stenosis had a possibility to worsen the balance of endocrine cell kinetics in stomach, and PGE2 in fundic mucosa would play a roll on the proliferation of D-cell in pyloric stenosis.
我们研究了给予幽门狭窄大鼠4周法莫替丁(15毫克/千克/天)对胃黏膜胃泌素细胞(G细胞)、生长抑素细胞(D细胞)和前列腺素E2(PGE2)的影响。结果显示,给予法莫替丁可增强幽门狭窄大鼠G细胞数量和血清胃泌素水平的升高。然而,给予法莫替丁可显著消除幽门狭窄时D细胞数量的增加,G/D细胞比值相应升高。此外,给予法莫替丁可降低胃底黏膜中PGE2浓度,而不改变幽门黏膜中PGE2浓度。我们的结果表明,在幽门狭窄时给予法莫替丁有可能恶化胃内分泌细胞动力学平衡,胃底黏膜中的PGE2在幽门狭窄时D细胞增殖中起作用。